Cookies help us improve your experience. We use cookies to improve website functionality and performance throughout upharma-c.com. Click "accept all cookies” to continue browsing the site with its full range of features enabled.

Strategy & Operations

We advise private companies, investment funds, non-governmental organizations and banks on strategic investment, business valuation, search for acquisition targets.

Strategic advisory services for Pharma & MedTech in CIS, Central Asia, South Caucasus

With a deep understanding of internal processes in healthcare, peculiarities of the supply chain in the pharmaceutical and medical equipment/devices markets, the specifics of relevant business models in our region, as well as the interests of all market stakeholders, we partner with our clients to deliver comprehensive and multifactor expertise for them.

(1) Supporting institutional investors. We offer full expert support of projects in the field of healthcare, pharmaceuticals, and medical technologies that require an assessment of risks and opportunities, justification of target's financial and marketing expectations, projects feasibility assessment, and others.

(2) Due diligence. UPharma Consulting has a proven track record of projects involved assignments to conduct due diligence of pre-investment and project financing deals in the region. We conduct commercial, marketing, and human resources due diligence for such projects.

(3) Expanding into the region. Side-by-side with our clients and elaborate on market entry expansion towards the countries of our region. The experience we offer is a part of our industry background and consists of comprehensive knowledge of the pharmaceutical market and internal business processes of Life Sciences companies.

(4) Research and deep dive. We know the region, people, and sources of information to dig in across CIS, Central Asia, and South Caucasus countries. Our research methods include comprehensive primary and secondary researches of information in all local languages, including the local industry experts and decision-makers.

Planning & Assessment
Target market opportunity assessment
Therapeutic area and core markets analyses
Competitors & consumers profiling
Marketing Authorization
Product reprocessingration routes
Early market access options
Authorities mapping
Timeline and budgeting for market entry
Price Reprocessingration
Price reprocessingration requirements
Documents needed
Procedure and timelining
>
National FormularyListing
Assessing local formulary listing requirements
KOLs and HCPs mapping
Process schemes and timelines
National Formulary Listing
Assessing local formulary listing requirements
KOLs and HCPs mapping
Process schemes and timelines

Regional Market Trends

Consumption acceleration driven by increasing diagnostic level, patients’ coverage, income growth and economic recovery, innovative therapies consumption increase.
Government budgets expansion in two directions: selected therapies budget increase (oncology, cardio etc.) and additional budget sources (e.g. compulsory health insurance in Kazakhstan, Azerbaijan, Uzbekistan).
Regulatory changes: ongoing healthcare reform in Ukraine, industry de-shadowing policies and tender process in Uzbekistan etc.
Pricing pressure: tight prices controls in Kazakhstan, Uzbekistan, and Azerbaijan, growing generics substitution.
Low penetration of medical services / diagnostic level (low educational level of physicians, diagnostic level for special diseases etc.
Local government initiatives / promotional restrictions: f2f visits restriction in Central Asia, prescription controls in Uzbekistan, official parallel import in Ukraine and Georgia.

Practice Leaders

Eugene BROVKO
Partner, Pharma & MedTech Market Access
Anastasiya MAXIMENKO
Partner, Recruitment & Organizational Development
RFP
Send us your Request For Proposal
file name

Download
our E-Brochure